USE OF BIOMARKERS IN THE ASSESSMENT OF THE EARLY TRANSITION FROM ARTERIAL HYPERTENSION TO HEART FAILURE

摘要

The present invention relates to a method of monitoring a medication in a subject subjected to said medication, said medication being selected from ACE inhibitors, angiotension receptor blockers and aldosterone antagonists. Also concerned is a method of deciding on the adaptation of a medication selected from ACE inhibitors, angiotension receptor blockers and aldosterone antagonists in a subject.